Speaker

---

Kevin Wiehe is the Norman L. Letvin Associate Professor of Medicine at Duke University and the Director of Research at the Duke Human Vaccine Institute. He is a computational immunologist whose research is focused on developing computational approaches to study B cell evolution. Dr. Wiehe’s work seeks to understand how broadly neutralising antibodies arise in response to rapidly evolving pathogens, with the ultimate goal of informing the design of next-generation vaccines.